EASD 2019 poster: diabetic foot risk detection with SUDOSCAN

Share on facebook
Share on twitter
Share on linkedin
Visuel-EASD-Home-Event

EASD 2019 POSTER:
DIABETIC FOOT RISK DETECTION

A multi-center study (3 hospitals: Bichat, La Pitié Salpêtrière, Bégin) completed in France established the link between the grade of diabetic foot risk and the decrease of Electrochemical Skin Conductance (ESC) measured with SUDOSCAN.
A poster has been presented at the European Association for the Study of Diabetes (EASD) conference in September 2019 (1).

SUDOSCAN IN DIABETOLOGY: DIABETIC FOOT RISK DETECTION

Percentage of neuropathies and severe neuropathies in patients with diabetes classified according to the gradation of diabetic foot risk.

Moreover, in a recent report, the French health department (HAS, Haute Autorité de Santé) has recommended that patients with diabetes be referred to podiatrists for prevention of foot lesions starting as soon as grade 1 foot risk (2).

 

References:
(1) Travert F, Sollier M, Potier L, Bianchi L, Gubranski G, Debbah E, Garcia C, Kadouch D, Dolz M, Allain J, Hansel B, Marre M, Bordier L, Roussel R. Lesions of the small fibers of the autonomic nervous system and gradation of the diabetic foot risk in patients with diabetes. Poster EASD 2019.
(2) HAS Argumentaire. Évaluation des actes réalisés par le pédicure-podologue pour la prévention des lésions, des pieds à risque de grade 1, chez le patient diabétique. Actualisation de l’évaluation conduite en 2007. Décembre 2018.

Impeto Medical

Impeto Medical

About SUDOSCAN

SUDOSCAN is a quick and non-invasive test that provides an accurate evaluation of sweat gland function therefore the small nerve fibers state within the peripheral autonomic nervous system.

With a quantitative and reproducible results, SUDOSCAN allows physicians to early detect and follow-up peripheral neuropathy to monitor disease progression and asses treatment efficacy for a better patient management.

SUDOSCAN efficacy has been tested for small nerve fiber neuropathies in several diseases and compared to guidelines reference tests.

Recent Posts

Subscribe to receive our scientific news

Name(Required)
Consent(Required)

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top